Table 2.
Antioxidants, Target Metabolic Enzymes, Cancer Cells Lines, and COX | IC50 (µg/mL) | |
---|---|---|
PGEO | Positive Controls | |
DPPH | 3.88 ± 0.45 | 1.88 ± 0.45 a |
Lipase | 478.14 ± 1.2 | 12.3 ± 0.33 b |
α-Amylase | 66.09 ± 1.43 | 6.64 ± 0.32 c |
α-Glucosidase | 52.44 ± 0.29 | 37.15 ± 0.33 c |
HeLa | 315.19 ± 2.05 | 0.84 ± 1.1 d |
MCF7 | 32.71 ± 1.25 | 0.37 ± 0.22 d |
Hep3B | 40.70 ± 1.89 | 1.21 ± 1.0 d |
COX-1 | 14.03 ± 1.74 | 5.72 ± 0.09 e |
COX-2 | 275.97 ± 2.08 | 0.0152 ± 0.007 e |
a Trolox, b Orlistat, c Acarbose, d Doxorubicin, and e Celecoxib.